Tweet
Greenleaf Trust raised its position in Baxter International Inc (NYSE:BAX) by 24.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 8,737 shares of the medical instruments supplier's stock after purchasing an additional 1,729 shares during the period. Greenleaf Trust's holdings in Baxter International were worth $645,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Global X Management Co. LLC raised its stake in Baxter International by 67.5% during the first quarter. Global X Management Co. LLC now owns 26,357 shares of the medical instruments supplier's stock worth $1,714,000 after acquiring an additional 10,618 shares in the last quarter. Daiwa Securities Group Inc. raised its stake in Baxter International by 7.4% during the first quarter. Daiwa Securities Group Inc. now owns 16,532 shares of the medical instruments supplier's stock worth $1,075,000 after acquiring an additional 1,146 shares in the last quarter. Sentry Investment Management LLC raised its stake in Baxter International by 9.2% during the first quarter. Sentry Investment Management LLC now owns 36,479 shares of the medical instruments supplier's stock worth $2,373,000 after acquiring an additional 3,067 shares in the last quarter. Dynamic Advisor Solutions LLC grew its holdings in shares of Baxter International by 21.0% during the first quarter. Dynamic Advisor Solutions LLC now owns 10,024 shares of the medical instruments supplier's stock worth $652,000 after purchasing an additional 1,739 shares during the last quarter. Finally, Commerzbank Aktiengesellschaft FI grew its holdings in shares of Baxter International by 24.2% during the first quarter. Commerzbank Aktiengesellschaft FI now owns 29,893 shares of the medical instruments supplier's stock worth $1,944,000 after purchasing an additional 5,834 shares during the last quarter. Institutional investors and hedge funds own 82.92% of the company's stock. Get Baxter International alerts:
Several analysts have recently commented on the company. Zacks Investment Research cut Baxter International from a "buy" rating to a "hold" rating in a report on Thursday, May 31st. JPMorgan Chase & Co. increased their target price on Baxter International from $80.00 to $85.00 and gave the stock an "overweight" rating in a report on Friday, July 27th. Citigroup increased their target price on Baxter International from $74.00 to $76.00 and gave the stock a "neutral" rating in a report on Tuesday, July 31st. Bank of America increased their target price on Baxter International from $73.00 to $83.00 and gave the stock a "buy" rating in a report on Tuesday, May 22nd. Finally, Piper Jaffray Companies assumed coverage on Baxter International in a report on Thursday, May 17th. They set an "overweight" rating and a $77.00 target price on the stock. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. The stock presently has a consensus rating of "Buy" and an average price target of $76.00. In related news, Director Carole J. Shapazian sold 5,400 shares of the firm's stock in a transaction dated Wednesday, August 8th. The stock was sold at an average price of $72.97, for a total value of $394,038.00. Following the transaction, the director now owns 15,248 shares in the company, valued at $1,112,646.56. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink . Also, SVP Brik V. Eyre sold 25,000 shares of the firm's stock in a transaction dated Tuesday, May 22nd. The shares were sold at an average price of $71.96, for a total value of $1,799,000.00. Following the completion of the transaction, the senior vice president now owns 128,777 shares in the company, valued at approximately $9,266,792.92. The disclosure for this sale can be found here . In the last quarter, insiders sold 74,877 shares of company stock worth $5,468,755. 0.07% of the stock is owned by company insiders.
Shares of BAX stock opened at $71.58 on Friday. The company has a current ratio of 2.62, a quick ratio of 2.00 and a debt-to-equity ratio of 0.39. The firm has a market cap of $38.20 billion, a PE ratio of 28.86, a price-to-earnings-growth ratio of 1.79 and a beta of 0.77. Baxter International Inc has a 52 week low of $60.53 and a 52 week high of $76.51.
Baxter International (NYSE:BAX) last posted its quarterly earnings results on Thursday, July 26th. The medical instruments supplier reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.06. The business had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.83 billion. Baxter International had a return on equity of 16.63% and a net margin of 8.29%. The firm's quarterly revenue was up 9.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.63 earnings per share. equities analysts predict that Baxter International Inc will post 2.98 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, October 1st. Investors of record on Friday, August 31st will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 1.06%. The ex-dividend date is Thursday, August 30th. Baxter International's dividend payout ratio is 30.65%.
Baxter International Profile
Baxter International Inc provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.
Read More: Average Daily Trade Volume Explained
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX). Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter 